Asio Capital’s iShares Biotechnology ETF IBB Stock Holding History

Asio Capital’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-18,968	Closed	-$2.9M	–	126
2021 Q4	$2.9M	Buy	18,968 +497	+3%	+$76.9K	0.9%	48
2021 Q3	$2.99M	Buy	18,471 +559	+3%	+$94.1K	1.03%	41
2021 Q2	$2.93M	Buy	17,912 +1,041	+6%	+$160K	1.04%	41
2021 Q1	$2.54M	Buy	16,871 +3,670	+28%	+$583K	1.05%	44
2020 Q4	$2M	Buy	13,201 +665	+5%	+$95K	0.96%	52
2020 Q3	$1.7M	Buy	12,536 +1,787	+17%	+$242K	0.93%	55
2020 Q2	$1.47M	Buy	+10,749	New	+$1.37M	0.93%	54

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Asio Capital's IBB Position: Q1 2022 in Review

Asio Capital sold out of iShares Biotechnology ETF (IBB) in Q1 2022, closing a stake of 18,968 shares — an estimated $2.9M sold.

Asio Capital first reported a position in IBB in Q2 2020 and held it in 7 quarters. The position peaked at $2.99M in Q3 2021. 898 funds tracked by Wall St. Rank hold IBB as of Q1 2022.

Asio Capital reported no remaining iShares Biotechnology ETF position as of Q1 2022 after selling out during the quarter.
Asio Capital sold 18,968 iShares Biotechnology ETF shares in Q1 2022, an estimated $2.9M.
Asio Capital first reported a position in iShares Biotechnology ETF in Q2 2020 and held it in 7 quarters.
Asio Capital's iShares Biotechnology ETF position peaked at $2.99M in Q3 2021.
898 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q1 2022.

Based on Asio Capital's 13F filing for Q1 2022, filed 28 Apr 2022.